Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding - Part 3
In the final episode of this series, Dr. Justin Abbatemarco and Dr. Ruth Dobson discuss navigating conversations with women and their families about potential ocrelizumab exposure during pregnancy…
Read the full articleYou might also wanna read
Clinical perspectives on herbal galactagogues in lactation care: a nationwide cross-sectional survey of Indian gynaecologists
Background: Breastfeeding is a biologically complex process with critical implications for maternal and infant health. Despite strong global
Q&A 172: the OVERLORD-MS study
Rituximab vs. Ocrelizumab; which is superior?
Dr. LaTasha Seliby Perkins: A Maternal RSV Vaccination Discussion
Hear from family physician LaTasha Seliby Perkins, MD, FAAFP, on maternal RSV vaccination guidelines and recommendations and ways to overcom
Rituximab Noninferior to Ocrelizumab in Relapsing MS
Rituximab is noninferior to ocrelizumab in suppressing disease activity in newly diagnosed multiple sclerosis, with a similar incidence of a
CME | Let's Talk Flu Shots: Clearing the Air on Flu Vaccine Safety
In this episode of CME on the Go, Dr. Jason Marker, Dr. Tamaan Osbourne-Roberts, and Dr. Lauren Brown-Berchtold discuss the importance of in
CME | Contraception: The Comprehensive Conversation Our Patients Deserve to Have
In this episode of CME on the Go, our hosts discuss various birth control options and their clinical relevance. The podcast provides insight
Comments
Sign in to join the conversation.
No comments yet. Be the first.